Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Prostate Cancer | Research

Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative study

Authors: Alice Guan, Eduardo J. Santiago-Rodríguez, Benjamin I. Chung, Janet K. Shim, Laura Allen, Mei-Chin Kuo, Kathie Lau, Zinnia Loya, James D. Brooks, Iona Cheng, Mindy C. DeRouen, Dominick L. Frosch, Todd Golden, John T. Leppert, Daphne Y. Lichtensztajn, Qian Lu, Debora Oh, Weiva Sieh, Michelle Wadhwa, Matthew R. Cooperberg, Peter R. Carroll, Scarlett L. Gomez, Salma Shariff-Marco

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

Patients diagnosed with low-risk prostate cancer (PCa) are confronted with a difficult decision regarding whether to undergo definitive treatment or to pursue an active surveillance protocol. This is potentially further complicated by the possibility that patients and physicians may place different value on factors that influence this decision. We conducted a qualitative investigation to better understand patient and physician perceptions of factors influencing treatment decisions for low-risk PCa.

Methods

Semi-structured interviews were conducted among 43 racially and ethnically diverse patients diagnosed with low-risk PCa, who were identified through a population-based cancer registry, and 15 physicians who were selected to represent a variety of practice settings in the Greater San Francisco Bay Area.

Results

Patients and physicians both described several key individual (e.g., clinical) and interpersonal (e.g., healthcare communications) factors as important for treatment decision-making. Overall, physicians’ perceptions largely mirrored patients’ perceptions. First, we observed differences in treatment preferences by age and stage of life. At older ages, there was a preference for less invasive options. However, at younger ages, we found varying opinions among both patients and physicians. Second, patients and physicians both described concerns about side effects including physical functioning and non-physical considerations. Third, we observed differences in expectations and the level of difficulty for clinical conversations based on information needs and resources between patients and physicians. Finally, we discovered that patients and physicians perceived patients’ prior knowledge and the support of family/friends as facilitators of clinical conversations.

Conclusions

Our study suggests that the gap between patient and physician perceptions on the influence of clinical and communication factors on treatment decision-making is not large. The consensus we observed points to the importance of developing relevant clinical communication roadmaps as well as high quality and accessible patient education materials.
Appendix
Available only for authorised users
Literature
17.
go back to reference Cunningham M, Murphy M, Sweeney P, Richards HL. Patient reported factors influencing the decision-making process of men with localised Prostate cancer when considering active Surveillance-A systematic review and thematic synthesis. Psychooncology Published Online October. 2021;4. https://doi.org/10.1002/pon.5832. Cunningham M, Murphy M, Sweeney P, Richards HL. Patient reported factors influencing the decision-making process of men with localised Prostate cancer when considering active Surveillance-A systematic review and thematic synthesis. Psychooncology Published Online October. 2021;4. https://​doi.​org/​10.​1002/​pon.​5832.
18.
go back to reference Guan A, Shim JK, Allen L, et al. Factors that influence treatment decisions: a qualitative study of racially and ethnically diverse patients with low- and very low risk Prostate cancer. Cancer Med Published Online November. 2022;20:cam45405. https://doi.org/10.1002/cam4.5405.CrossRef Guan A, Shim JK, Allen L, et al. Factors that influence treatment decisions: a qualitative study of racially and ethnically diverse patients with low- and very low risk Prostate cancer. Cancer Med Published Online November. 2022;20:cam45405. https://​doi.​org/​10.​1002/​cam4.​5405.CrossRef
Metadata
Title
Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative study
Authors
Alice Guan
Eduardo J. Santiago-Rodríguez
Benjamin I. Chung
Janet K. Shim
Laura Allen
Mei-Chin Kuo
Kathie Lau
Zinnia Loya
James D. Brooks
Iona Cheng
Mindy C. DeRouen
Dominick L. Frosch
Todd Golden
John T. Leppert
Daphne Y. Lichtensztajn
Qian Lu
Debora Oh
Weiva Sieh
Michelle Wadhwa
Matthew R. Cooperberg
Peter R. Carroll
Scarlett L. Gomez
Salma Shariff-Marco
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11679-4

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine